Fluoroscopy Guided Femoral Arterial Access

Design: A prospective, randomized, controlled clinical trial to study the effectiveness of applying fluoroscopy guided femoral artery access in the cardiac catheterization lab and its effect on the usage of FDA approved femoral artery closure devices. This trial will randomize patients between fluoroscopy guided femoral artery access or femoral artery access using the usual anatomic landmarks and will then study the difference in the ability to use closure devices on the access site.

Purpose: To establish the safety and efficacy of using fluoroscopic assistance to allow access of the common femoral artery rather than its branches and thus increase the ability to use closure devices.

Enrollment: An approximate enrollment of up to 1000 patients (all patients randomized) who will be undergoing cardiac catheterization and who meet all the eligibility criteria at OUMC and VAMC in Oklahoma City.

Duration: The study will be conducted over approximately one year.

Primary Endpoint: Prediction of ability to use femoral artery closure device based on angiographic data of the femoral artery from fluoroscopy arm versus traditional technique arm.

Secondary Endpoints:

• Compare the incidence of known major side effects of femoral artery puncture between the two methods of access
• Compare the time and number of attempts needed to obtain arterial access between the two groups of patients.
• Compare the ability to puncture the common femoral artery using fluoroscopy vs. anatomical landmarks among different levels of trainees (cardiology fellows) and attending cardiologists.
• Assess whether fluoroscopic guidance is a superior method to obtain access and thus should be used as a training technique for cardiology fellows.

Analytical Subset: Intention-to-treat sample

Inclusion criteria

• Age 18 and over.
• Patients undergoing elective or urgent left heart cath from the femoral approach.
• Willingness to participate and sign the consent form.

Exclusion criteria

• Access from site other than the common femoral artery.
• Creatinine >= 3.0mg/dl.
• Graft in the common femoral artery or other surgeries at that site that might have changed the anatomy of the groin.
• Unable or refusal to sign a consent form.
• Patients from the Department of Corrections.
• Pregnant Women
• Undetectable femoral artery pulse.
• Patients undergoing emergent cardiac catheterization for ST elevation MI or unstable ACS.